Numerous life science transactions, including equity financing rounds in Ascendis Pharma, Hoba Therapeutics, IO Biotech, Solid Therapeutics, Viobac etc.

Numerous life science transactions, including equity financing rounds in Ascendis Pharma, Hoba Therapeutics, IO Biotech, Solid Therapeutics, Viobac, UNION therapeutics, Synklino, Cinical Microbiomics, sale of Santaris Pharma (acquired by Roche), acquisitions of PDE4i/Orismilast from LEO Pharma, Twelve Bio and acquisition of Tetramer Shop by 10x Genomics, Cosmos-ID, DNASense, MS-Omics by Clinical Microbiomics for a combined value of approximately DKK 7bn